---
figid: PMC3035360__JBB2011-583929.001
figtitle: Synthetic view of the p53 pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC3035360
filename: JBB2011-583929.001.jpg
figlink: /pmc/articles/PMC3035360/figure/fig1/
number: F1
caption: A synthetic view of the p53 pathway.  Mutant p53 exerts new oncogenic activities,
  so-called “gain-of-function” (GOF) activities, which can contribute actively to
  various stages of tumor progression, including distant metastases, and to increased
  resistance to anticancer treatments.
papertitle: TP53 Mutations in Nonsmall Cell Lung Cancer.
reftext: Akira Mogi, et al. J Biomed Biotechnol. 2011;2011:583929.
year: '2011'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.6181992
figid_alias: PMC3035360__F1
figtype: Figure
redirect_from: /figures/PMC3035360__F1
ndex: d3af8314-df1a-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3035360__JBB2011-583929.001.html
  '@type': Dataset
  description: A synthetic view of the p53 pathway.  Mutant p53 exerts new oncogenic
    activities, so-called “gain-of-function” (GOF) activities, which can contribute
    actively to various stages of tumor progression, including distant metastases,
    and to increased resistance to anticancer treatments.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ABL1
  - MYC
  - E2F1
  - UBE2L3
  - KRAS
  - HRAS
  - NRAS
  - TP53
  - TP63
  - TP73
  - PML
  - MAP2K3
  - ID4
  - PLK2
  - PIN1
  - PDZD2
  - MDM2
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - BAX
  - BBC3
  - Cancer
---
